Clinical trial Recruiting at 2 sites Phase 3 Interventional Ages 18 to 80

Injection of amniotic suspension allograft for knee osteoarthritis treatment

Official title: The Efficacy of Amniotic Suspension Allograft Injection in the Treatment of Knee Osteoarthritis: a Randomized Double-blind Controlled Trial

Run by Chang Gung Memorial Hospital · NCT06704893 · Data updated 2026-11-12

This study is testing if injections of amniotic suspension allograft can help people with knee osteoarthritis feel less pain and move better compared to other treatments.

More Osteoarthritis trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment160 (estimated)
SponsorChang Gung Memorial Hospital
Academic / other
Locations2 sites (Kaohsiung, Taiwan and 1 other locations)
StatusRecruiting
StartedOctober 21, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJanuary 26, 2026
Trial IDNCT06704893 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18 to 80 with symptomatic knee osteoarthritis and a pain score greater than 4.

Probably not a fit

Patients who are pregnant, regularly use anticoagulants, or have had recent knee surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of amniotic suspension allograft (ASA) injections compared to hyaluronic acid (HA) and saline in treating knee osteoarthritis. It is a double-blind randomized controlled trial involving participants aged 18 to 80 with symptomatic knee osteoarthritis. The study aims to determine the optimal dosage of ASA and its impact on reducing inflammation and improving pain and mobility. Participants will be monitored for their pain levels and overall quality of life throughout the trial.

Why it matters

Potential benefit: If successful, this treatment could provide a new, effective non-surgical option for alleviating pain and improving mobility in patients with knee osteoarthritis.

How similar studies have gone: Other studies have shown promising results with similar approaches using placental-derived tissues for orthopedic conditions, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18 and 80 years.
2. Body mass index (BMI) less than 40 kg/m².
3. Symptomatic knee osteoarthritis with X-ray evidence graded 2 or 3 on the Kellgren-Lawrence (KL) grading scale.
4. Numerical Rating Scale (NRS) score (scale 1 to 10) for pain greater than 4 over the past 7 days.
5. Able to walk independently or with the aid of a cane.

Exclusion Criteria:

1. Pregnant women or women planning pregnancy.
2. Regular use of anticoagulants.
3. Use of pain medications (except acetaminophen) within 15 days prior to injection.
4. History of substance abuse.
5. Patients who take additional knee symptom-relief medications during the study must report it to the research team; failure to comply will result in exclusion.
6. Corticosteroid or visco-supplementation injection into the affected knee within 3 months prior to enrollment.
7. Knee surgery on the affected side within 12 months before enrollment, or surgery on the contralateral knee within 6 months before enrollment.

9\. History of organ or hematopoietic stem cell transplant. 11. Current use of immunosuppressive agents. 12. Diagnosis of cancer within the past 5 years (except for treated basal cell carcinoma).

Where it's running

  • Kaohsiung Chang Gung Memorial Hospital
    Kaohsiung, Taiwan, Taiwan
    Recruiting
  • Department of Physical Medicine and Rehabilitation, Kaohsiung Chang Gung Memorial Hospital
    Kaohsiung City, Taiwan
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.